Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma - Summary - MDSpire

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma

  • By

  • Carmina Muñoz Bastidas

  • Mario Tapia Tapia

  • Andrés Calva López

  • Vanessa Talavera Cobo

  • Juan Colombas Vives

  • Eduardo Miraval Wong

  • Cristina Gutiérrez Castané

  • Francisco Javier Ancizu Marckert

  • Marcos Torres Roca

  • Luis Labairu Huerta

  • Fernando Diez-Caballero Alonso

  • José Enrique Robles García

  • Felipe Villacampa Aubá

  • Daniel González Padilla

  • Bernardino Miñana López

  • Daniel Sánchez Zalabardo

  • October 29, 2024

  • 0 min

Share

Objective:

To assess the impact of TFE3 rearrangement on RCC recurrence and explore the diagnostic insights provided by IHC staining, particularly its predictive value.

Key Findings:
  • TFE3-rearranged RCC accounted for 1.15% of cases in the study, indicating its rarity and potential for underdiagnosis.
  • Patients with TFE3-rearranged RCC were younger (median age 49) compared to ccRCC patients, which may influence treatment decisions.
  • TFE3-rearranged RCC had a higher recurrence rate (50% vs. 18%) than ccRCC, suggesting a need for closer monitoring.
  • TFE3 rearrangement was identified as an independent prognostic factor for recurrence (HR = 4.6), emphasizing its clinical relevance.
  • TFE3-rearranged RCC showed shorter progression-free survival compared to ccRCC, highlighting its aggressive nature.
Interpretation:

TFE3 rearrangement is a significant prognostic factor in RCC, associated with increased recurrence and shorter progression-free survival. This underscores the need for improved diagnostic methods to accurately identify TFE3 rearrangement.

Limitations:
  • Limited sample size of TFE3-rearranged RCC cases may affect the generalizability of the findings.
  • Potential biases in retrospective study design could influence the results and interpretations.
Conclusion:

TFE3-rearranged RCC is a distinct molecular subtype with implications for prognosis and diagnosis, necessitating further research to clarify its clinical significance, particularly in treatment strategies.

Original Source(s)

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma

  • by Carmina Muñoz Bastidas, Mario Tapia Tapia, Andrés Calva López, Vanessa Talavera Cobo, Juan Colombas Vives, Eduardo Miraval Wong, Cristina Gutiérrez Castané, Francisco Javier Ancizu Marckert, Marcos Torres Roca, Luis Labairu Huerta, Fernando Diez-Caballero Alonso, José Enrique Robles García, Felipe Villacampa Aubá, Daniel González Padilla, Bernardino Miñana López, Daniel Sánchez Zalabardo

  • October 29, 2024

Related Content

Systematic Review of Urinary Biomarkers for the Detection of Renal Cell Carcinoma

Defining a threshold for safe surgical management of vena cava thrombus in renal cell carcinoma patients: evidence from German total population data with 3,700 cases from 2006 to 2020

Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?